Novo Holdings A/S Long-Term Concentrated

CIK: 0001388325 · Show all filings

Period: Q1 2019 (← Previous) (Next →)

Filing Date: May 15, 2019

Total Value ($000): $675,969 (100.0% shares, 0.0% debt)

Holdings (22)

INGN INOGEN INC 50.1%

Value ($000) $338,499 Shares 3,549,320 Est. Cost $17.78 Unrealized +601.5%

GKOS GLAUKOS CORP 7.0%

Value ($000) $47,435 Shares 605,266 Est. Cost $30.48 Unrealized +119.1%

CABO CABLE ONE INC 6.5%

Value ($000) $44,162 Shares 45,000 Est. Cost $833.27 Unrealized 0.0%

KIDS ORTHOPEDIATRICS CORP 4.3%

Value ($000) $28,951 Shares 654,549 Est. Cost $18.69 Unrealized +103.5%

FOLD AMICUS THERAPEUTICS INC 3.8%

Value ($000) $25,403 Shares 1,867,870 Est. Cost $14.29 Unrealized -14.5%

AKBA AKEBIA THERAPEUTICS INC 3.8%

Value ($000) $25,389 Shares 3,100,000 Est. Cost $12.34 Unrealized -44.4%

— AERIE PHARMACEUTICALS INC 3.2%

Value ($000) $21,409 Shares 450,714 Est. Cost $60.85 Unrealized —

— SEASPINE HLDGS CORP 2.9%

Value ($000) $19,725 Shares 1,308,037 Est. Cost $12.38 Unrealized —

CRVS CORVUS PHARMACEUTICALS INC 2.6%

Value ($000) $17,770 Shares 4,420,516 Est. Cost $13.03 Unrealized -67.6%

SIBN SI BONE INC 2.5%

Value ($000) $16,818 Shares 892,685 Est. Cost $18.92 Unrealized +2.3%

— ENTASIS THERAPEUTICS HLDGS I 2.2%

Value ($000) $14,749 Shares 2,181,843 Est. Cost $10.88 Unrealized —

GLPG GALAPAGOS NV 1.7%

Value ($000) $11,481 Shares 97,481 Est. Cost $112.97 Unrealized —

— NABRIVA THERAPEUTICS PLC 1.7%

Value ($000) $11,477 Shares 4,703,720 Est. Cost $7.20 Unrealized —

INSP INSPIRE MED SYS INC 1.5%

Value ($000) $9,937 Shares 175,000 Est. Cost $42.52 Unrealized +27.1%

— ACCELERON PHARMA INC 1.4%

Value ($000) $9,233 Shares 198,261 Est. Cost $27.65 Unrealized —

STIM NEURONETICS INC 1.2%

Value ($000) $8,006 Shares 525,000 Est. Cost $30.40 Unrealized -45.6%

— MERUS N V 1.1%

Value ($000) $7,426 Shares 502,795 Est. Cost $7.99 Unrealized —

— BLUEPRINT MEDICINES CORP 0.8%

Value ($000) $5,409 Shares 67,567 Est. Cost $80.05 Unrealized —

— VERONA PHARMA PLC 0.7%

Value ($000) $4,815 Shares 740,740 Est. Cost $11.66 Unrealized —

CRNX CRINETICS PHARMACEUTICALS IN 0.5%

Value ($000) $3,073 Shares 135,009 Est. Cost $29.69 Unrealized -17.2%

— DERMIRA INC 0.4%

Value ($000) $2,724 Shares 201,059 Est. Cost $30.14 Unrealized —

— UNUM THERAPEUTICS INC 0.3%

Value ($000) $2,078 Shares 473,441 Est. Cost $47.61 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
INGN	INOGEN INC	3,549,320	$338,499	50.1%	$17.78	+601.5%	COM	45780L104
GKOS	GLAUKOS CORP	605,266	$47,435	7.0%	$30.48	+119.1%	COM	377322102
CABO	CABLE ONE INC	45,000	$44,162	6.5%	$833.27	0.0%	COM	12685J105
KIDS	ORTHOPEDIATRICS CORP	654,549	$28,951	4.3%	$18.69	+103.5%	COM	68752L100
FOLD	AMICUS THERAPEUTICS INC	1,867,870	$25,403	3.8%	$14.29	-14.5%	COM	03152W109
AKBA	AKEBIA THERAPEUTICS INC	3,100,000	$25,389	3.8%	$12.34	-44.4%	COM	00972D105
—	AERIE PHARMACEUTICALS INC	450,714	$21,409	3.2%	$60.85	—	COM	00771V108
—	SEASPINE HLDGS CORP	1,308,037	$19,725	2.9%	$12.38	—	COM	81255T108
CRVS	CORVUS PHARMACEUTICALS INC	4,420,516	$17,770	2.6%	$13.03	-67.6%	COM	221015100
SIBN	SI BONE INC	892,685	$16,818	2.5%	$18.92	+2.3%	COM	825704109
—	ENTASIS THERAPEUTICS HLDGS I	2,181,843	$14,749	2.2%	$10.88	—	COM	293614103
GLPG	GALAPAGOS NV	97,481	$11,481	1.7%	$112.97	—	SPON ADR	36315X101
—	NABRIVA THERAPEUTICS PLC	4,703,720	$11,477	1.7%	$7.20	—	SHS	G63637105
INSP	INSPIRE MED SYS INC	175,000	$9,937	1.5%	$42.52	+27.1%	COM	457730109
—	ACCELERON PHARMA INC	198,261	$9,233	1.4%	$27.65	—	COM	00434H108
STIM	NEURONETICS INC	525,000	$8,006	1.2%	$30.40	-45.6%	COM	64131A105
—	MERUS N V	502,795	$7,426	1.1%	$7.99	—	COM	N5749R100
—	BLUEPRINT MEDICINES CORP	67,567	$5,409	0.8%	$80.05	—	COM	09627Y109
—	VERONA PHARMA PLC	740,740	$4,815	0.7%	$11.66	—	SPONSORED ADS	925050106
CRNX	CRINETICS PHARMACEUTICALS IN	135,009	$3,073	0.5%	$29.69	-17.2%	COM	22663K107
—	DERMIRA INC	201,059	$2,724	0.4%	$30.14	—	COM	24983L104
—	UNUM THERAPEUTICS INC	473,441	$2,078	0.3%	$47.61	—	COM	903214104